In this podcast episode, Anousha and Bright invited Dr. Robert Gish to speak about hepatitis B Reactivation, a serious health issue often overlooked in the discourse surrounding hepatitis B and liver cancer.
More than 2.4 million cases of chlamydia, gonorrhea, and syphilis were reported in the U.S. in 2023. Still, the numbers show the cases of reportable STIs tended to decrease, or at least saw a sharp decline in the rate by which they increased. In this episode of the Sex+Health podcast, we talk with Bradley Stoner, MD, PhD, the Director of the Centers for Disease Control and Prevention Division of STD Prevention, for his thoughts on what's driving the epidemic and why the latest data show there may be cause for optimism.
Reported Tuberculosis in the United States, 2023 provides the most current and complete data for tuberculosis in the U.S.
Sexually Transmitted Infections Surveillance, 2023 provides the most current and complete data for three nationally notifiable STIs: chlamydia, gonorrhea, and syphilis, including congenital syphilis.
During this insightful webinar, survivor and cervical cancer advocate Karla Chavez and Dr. Stephanie Alimena engaged in an insightful conversation around cervical cancer screening. They discussed how HPV tests work, the shift in screening options, and what patients can expect during screenings. The speakers also shared valuable advice on how to talk with your doctors about the latest developments in HPV screening. It was an informative and eye-opening event—thank you to everyone who joined us to learn more about their health!
NASTAD highlights the achievements of the 47 Ending the HIV Epidemic (EHE) Phase 1 jurisdictions through a series of success stories featured on a dedicated webpage. These stories demonstrate innovative strategies addressing the four pillars of EHE: Diagnose, Treat, Prevent, and Respond. Supported by the Health Resources and Services Administration (HRSA), this initiative aims to strengthen programs for individuals living with and at risk for HIV.
A poster that describes the TB blood test, explains what a positive blood test means, and emphasizes that TB is treatable. This material was designed to be displayed in civil surgeon offices to explain TB screening as part of the immigration medical examination.
This information guide is intended for health care professionals involved in care of persons interested in or receiving doxycycline postexposure prophylaxis (doxy PEP) for STI prevention. The information in this guide pertains to the use of doxy PEP for STI postexposure prophylaxis.
This webinar discusses that with reported cases of syphilis up 80% since 2018 and more than 3,700 babies born with syphilis in 2022, it’s important to learn more about this curable STI and how to protect yourself from serious health consequences.
The WHO Global tuberculosis report 2024 provides a comprehensive and up-to-date assessment of the TB epidemic and of progress in prevention, diagnosis and treatment of the disease, at global, regional and country levels. This is done in the context of global TB commitments, strategies and targets.
The 2024 edition of the report is, as usual, based primarily on data gathered by WHO from national ministries of health in annual rounds of data collection. In 2024, 193 countries and areas with more than 99% of the world’s population and TB cases reported data.
